Oncology
Immune Checkpoint Inhibitor Combination Efficacious for Patients With High-grade Neuroendocrine Carcinoma
Latest in Endocrinology
Reuters Health • The Doctor's Channel Daily Newscast
Stringent glucose control may not benefit sicker diabetics
Dec 15, 2009
| Cardiology, Diabetes, Endocrinology, Family Medicine, Hospitalist, Internal Medicine, Medical Students, Nephrology, Nurses/NP/PA, Public Health & Prevention, Reuters Health • The Doctor's Channel Newscast
NEW YORK (Reuters Health) – In type 2 diabetics with multiple comorbidities, tight glycemic control does not provide the same cardiovascular benefits that it does in diabetics with fewer diseases, new research suggests. In the December 15 Annals of Internal Medicine, the investigators note that post hoc...
Reuters Health • The Doctor's Channel Daily Newscast
Sulfonylureas carry higher mortality, heart failure risks than metformin
Dec 9, 2009
| Cardiology, Critical Care, Diabetes, Endocrinology, Family Medicine, Hospitalist, Internal Medicine, Medical Students, Nurses/NP/PA, Pharmacists, Reuters Health • The Doctor's Channel Newscast
NEW YORK (Reuters Health) - New research shows that antidiabetes agents are not equal when it comes to cardiovascular risks and mortality.
According to a report in the December 4th Online First issue of BMJ, first and second generation sulfonylureas have a 24% to 61% excess risk for all cause...
Why insulin-like growth factor is important
Graves’ Eye Disease and IGF-1
Robert Goldberg, MD, Chief, Orbital and Opthalmic Plastic Surgery, David Geffen School of Medicine UCLA, discusses new advances on the medical and surgical sides of Graves’ Eye Disease, and in particular, the IGF antibody and its relationship to TSH. Reading: Matos K, Manso PG, Marback E, Furlanetto...
Diabesity and metabolic syndrome
Dec 7, 2009
Seasonal variation seen in brown adipose tissue
Nov 25, 2009
